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Annotation: Cutaneous leishmaniasis is a widespread tropical infection caused by many different 
species of Leishmania protozoa, which are transmitted by mosquitoes. Its clinical manifestations are 
extremely diverse and depend on many parasite and host factors that are poorly understood. Uzbekistan 
is also one of the epidemiological regions for cutaneous leishmaniasis. The article presents a collection 
of age, gender and inter-district statistics for the Bukhara region. 
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Leishmaniasis is a zoonotic disease caused by an obligate intracellular protozoan parasite of the 
genus Leishmania, which maintains its life cycle by transmitting infection from the sand fly to the 
mammalian host [1]. 
The annual number of newly registered cases of leishmaniasis in 2008 was about 400 15 thousand 
[2], and by 2013 it reached 1.5-2 million [3]. 
On the territory of the Republic of Uzbekistan there are two natural focal zones of cutaneous 
leishmaniasis: [4.5.6.] 1. Highly active, which includes: Surkhandarya (Termez, Angora and Muzrabad 
districts), Bukhara, Karshi, Navoi, Jizzakh regions. 2. Inactive: Autonomous Republic of  
Karakalpakstan, Kyzyl Kum desert. 
The age composition of patients with cutaneous leishmaniasis is also gradually changing; if at the 
end of the last century, pediatric patients prevailed, in recent years it is predominantly the adult 
population, about 75-90% of cases [7,8]. 
Epidemiological studies have shown that cutaneous leishmaniasis is characterized by a certain 
seasonality [9,10]. The first patients appear at the end of May, then the incidence increases, reaching its 
maximum in September-October, and then there is a gradual decline in the incidence, when in 
December and January there are already isolated patients with cutaneous leishmaniasis, and in these 
cases, it is usually late visiting patients with cutaneous leishmaniasis [11,12,13]. 
Currently, in the countries of Central Asia, visceral and cutaneous (urban type) leishmaniasis is 
practically eliminated, however, zoonotic cutaneous leishmaniasis (ZCL) continues to occupy a certain 
place in the regional pathology [14, 15]. 
It should be emphasized that the nature and type of settlements of natural carriers of the pathogen 
are changing, settlement populations of mosquitoes appear [16,17]. Analysis of the long-term incidence 
of CL shows that rises are observed in about 5-7 years and can continue for 2-3 years in a row [18]. 
In humans, the typical course of zoonotic cutaneous leishmaniasis is caused only by L. major, but 
L. turanica, as shown by limited studies, can cause abortive dermatosis in humans and lead to their 
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subsequent resistance to L. major [19 ]. 
Purpose of the study 
Collection of statistics of cutaneous leishmaniasis in Bukhara region by age, sex and regions 
Material and research methods 
Based on the set goals and objectives of the research, we examined and treated 90 patients with 
zoonotic cutaneous leishmaniasis, who are residents of the Bukhara region of the Republic of 
Uzbekistan. 
RESULTS AND DISCUSSION 
Figure 1 shows patients with cutaneous leishmaniasis depending on the place of residence. 
 Note: 1 - Peshku, 2 - 
Gendar, 3 - Vobkent, 4 - Romitan, 5 - Kagan, 6 - Gijduvan, 7 - Shafrikan, 8 - Karakul, 9 - Bukhara and 
Bukhara region, 10 – Olot 
Rice. 1. Distribution of patients with CL depending on the place of residence 
As can be seen from Fig. 1, the largest number of patients were residents of the Shafrikan region, 
the area of which is characterized by semi-desert and, due to their professional activities, patients were 
constantly in the most epidemic centers of CL. 
As can be seen from the data presented, all patients with CL are residents of different regions of 
the Bukhara region. In this regard, it was not possible to accurately determine the incubation period of 
cutaneous leishmaniasis in this sample of patients. 
When studying the anamnesis of patients, it was found that in most patients at the beginning of the 
disease, specific rashes of bright red color, the size of a pea, appeared in various areas of the skin, which 
were accompanied by moderate subjective sensations and slight edema. Ulceration was observed in 
patients on average 15-20 days after the appearance of tubercles. As a rule, in the central part of the 
formed tubercles, punctate necrosis developed with the formation of a dense dark crust on the surface. 
When the latter was removed, the bottom of the ulcer was whitish in color with insignificant serous 
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discharge. It should be noted that leishmaniomas increased in size due to the disintegration of the 
surrounding infiltrate. In some cases, there was a peripheral growth of leishmaniasis ulcers as a result of 
which extensive lesions were formed, of a directional form with abundant purulent-necrotic discharge. 
According to the clinical forms, the patients were distributed, according to the classification of  P. 
V. Kozhevnikov, as follows: ulcerated leishmaniomas without complications (group 1 of patients) were 
observed in 38 (31.7%) patients; leishmaniomas with lymphangitis and lymphadenitis (group 2 of 
patients) - in 28 (23.3%) patients; leishmaniomas with tubercles of seeding (group 3 of patients) - in 25 
(20.8%) patients; leishmaniasis with lymphangoites and tubercles of seeding (group 4) - in 29 (24.2%) 
patients with zoonotic cutaneous leishmaniasis. 
The distribution of patients by gender and clinical forms of zoonotic cutaneous leishmaniasis in 
percentage and number is shown in Figure 
2.  Rice. 2. 
Clinical distribution of patients with CL by gender 
accessories 
As can be seen from the data presented, there were no significant differences in clinical 
manifestations in males and females, since the studied forms occurred with approximately the same 
frequency. Thus, ulcerated leishmanioma occurred in 19.2% of men and in 12.5% of women. Therefore, 
in the future, the considered clinical forms can be generalized into one group, regardless of gender. 
Next, we were interested in the question of the possible relationship between the age of the 
patients themselves and the clinical manifestations of zoonotic cutaneous leishmaniasis. The results of 
this analysis are presented by us in Table 1. 
As can be seen from the data presented in Table 1, mainly patients with various clinical variants 
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of CL were between the ages of 20 and 50 (72.5%), which confirms the urgency of this problem, since 
the disease occurs in an active, able-bodied population that is actively moves and gets bitten by 
mosquitoes. 
Table 3.1 
Distribution of patients with CL by age 
Group 
Up to 20 years 20-30 31-40 41-50 Over 50 
abs % abs % abs % abs % abs % 
1, n=28 5 5,6 6 6,7 4 4,4 7 7,8 6 6,7 
2, n=18 4 4,4 8 8,9 3 3,3 2 2 1 1 
3, n=25 5 5,6 8 8,9 4 4,4 5 5,6 3 3,3 
4, n=19 4 4,4 7 7,8 2 2 4 4,4 2 2 
Total 18 20 29 32,3 13 14,1 18 19,8 12 13 
 
The effectiveness of treatment is influenced by the timing of any disease, including zoonotic 
cutaneous leishmaniasis, which was analyzed and presented in Figure 3. 
As can be seen from the data presented, the largest number of patients (89.2%) was with a disease 
duration of up to 45 days. This indicates a late appeal of patients for medical help, when complications 
of CL are already developing, which will subsequently lead to torpidity in relation to the treatment 
being carried out. 
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